Cargando…

Immune Responses in Cutaneous Leishmaniasis: In vitro Thelper1/Thelper2 Cytokine Profiles Using Live Versus Killed Leishmania major

BACKGROUND: Recovery from cutaneous leishmaniasis (CL) leads to protection against further lesion development. In contrast, vaccination using killed parasites does not induce enough protection; the reason(s) is not currently known but might be related to different immune response induced against liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miramin-Mohammadi, Akram, Javadi, Amir, Eskandari, Seyyed Ebrahim, Nateghi-Rostami, Mahmood, Khamesipour, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271235/ https://www.ncbi.nlm.nih.gov/pubmed/34277861 http://dx.doi.org/10.18502/jad.v15i1.6491

Ejemplares similares

Immune response in cutaneous leishmaniasis patients with healing vs. non-healing lesions
por: Miramin-Mohammadi, Akram, et al.
Publicado: (2020)

Comparison of cytokine profile of IFN-γ, IL-5 and IL-10 in cutaneous leishmaniasis using PBMC vs. whole blood
por: Mohammadi, Akram Miramin, et al.
Publicado: (2019)

Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica: study protocol for a randomized, controlled trial
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2021)

Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2018)

Cutaneous Leishmaniasis in Suspected Patients Referred To the Center for Research and Training in Skin Diseases and Leprosy, Tehran, Iran from 2008 To 2011
por: MOHAMMADI, Akram MIR AMIN, et al.
Publicado: (2013)

Immunization Against Cutaneous Leishmaniasis by Alginate Microspheres Loaded With Autoclaved Leishmania Major (ALM) and Quillaja Saponins
por: Tafaghodi, Mohsen, et al.
Publicado: (2016)

Efficacy of Microwave and Infrared Radiation in the Treatment of the Skin Lesions Caused by Leishmania major in an Animal Model
por: Eskandari, SE, et al.
Publicado: (2012)

The efficacy of hydro alcoholic extract of Seidlitzia rosmarinus on experimental zoonotic cutaneous leishmaniasis lesions in murine model
por: Ahmadi, Maryam, et al.
Publicado: (2014)

Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial
por: ESKANDARI, Seyed Ebrahim, et al.
Publicado: (2019)

Potential biomarkers of immune protection in human leishmaniasis
por: Rostami, Mahmoud Nateghi, et al.
Publicado: (2021)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

CD8(+) T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis
por: Nateghi Rostami, Mahmoud, et al.
Publicado: (2010)

Performance of a universal PCR assay to identify different Leishmania species causative of Old World cutaneous leishmaniasis
por: Nateghi Rostami, Mahmoud, et al.
Publicado: (2020)

Evaluation of a Possible Synergistic Effect of Meglumine Antimoniate with Paromomycin, Miltefosine or Allopurinol on in Vitro Susceptibility of Leishmania tropica Resistant Isolate
por: REZAEI RIABI, Tahereh, et al.
Publicado: (2013)

Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major
por: Hoseini, Shervin G., et al.
Publicado: (2012)

Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major
por: Hoseini, Shervin Ghaffari, et al.
Publicado: (2014)

Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis
por: Hejazi, SH, et al.
Publicado: (2012)

Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major induced Cutaneous Leishmaniasis
por: Hejazi, SH, et al.
Publicado: (2012)

Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites
por: Hadighi, Ramtin, et al.
Publicado: (2006)

Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum
por: Boussoffara, Thouraya, et al.
Publicado: (2019)

Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial
por: Javadi, Amir, et al.
Publicado: (2022)

Successful Isolation of Leishmania RNA Virus (LRV) from Leishmania major in a Cutaneous Leishmaniasis Focus in Central Iran: An Update on Cases
por: Moin-Vaziri, Vahideh, et al.
Publicado: (2022)

Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani
por: Wijesooriya, Hiruni, et al.
Publicado: (2023)

Cutaneous Leishmaniasis Due to Leishmania aethiopica
por: van Henten, Saskia, et al.
Publicado: (2019)

Treatment of Cutaneous Lesion of 20 Years’ Duration Caused by Leishmanization
por: Khamesipour, Ali, et al.
Publicado: (2012)

Super Infection of Cutaneous Leishmaniasis Caused by Leishmania major and L. tropica to Crithidia fasciculata in Shiraz, Iran
por: MIRZAPOUR, Aliyar, et al.
Publicado: (2019)

Lived Experiences of Patients Suffering from Acute Old World Cutaneous Leishmaniasis: A Qualitative Content Analysis Study from Iran
por: Khatami, Alireza, et al.
Publicado: (2018)

Cutaneous sporotrichoid leishmaniasis: An atypical case caused by Leishmania major
por: Bassaid, Adila, et al.
Publicado: (2022)

Assessment of intralesional cytokine profile of cutaneous leishmaniasis caused by Leishmania donovani in Sri Lanka
por: Galgamuwa, Lahiru Sandaruwan, et al.
Publicado: (2019)

Distinct plasma chemokines and cytokines signatures in Leishmania guyanensis-infected patients with cutaneous leishmaniasis
por: de Mesquita, Tirza Gabrielle Ramos, et al.
Publicado: (2022)

The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis
por: Carneiro, Pedro Paulo, et al.
Publicado: (2016)

Leishmania donovani and Cutaneous Leishmaniasis, Sri Lanka
por: Siriwardana, H. V. Yamuna D., et al.
Publicado: (2007)

Cutaneous Leishmaniasis Caused by Leishmania killicki, Algeria
por: Izri, Arezki, et al.
Publicado: (2014)

Imported cutaneous leishmaniasis: molecular investigation unveils Leishmania major in Bangladesh
por: Khan, Md Anik Ashfaq, et al.
Publicado: (2019)

Molecular Detection of Leishmania major in Hemiechinus auritus: A Potential Reservoir of Zoonotic Cutaneous Leishmaniasis in Damghan, Iran
por: Pourmohammadi, Behrad, et al.
Publicado: (2019)

First Report of Natural Infection of Phlebotomus mongolensis to Leishmania major and Leishmania turanica in the Endemic Foci of Zoonotic Cutaneous Leishmaniasis in Iran
por: Absavaran, Azad, et al.
Publicado: (2022)

Development of Cutaneous Leishmaniasis after Leishmania Skin Test
por: Machado, Paulo R., et al.
Publicado: (2011)

Therapy of cutaneous leishmaniasis caused by Leishmania braziliensis with fluconazole
por: Veraldi, Stefano, et al.
Publicado: (2021)

Efficacy of Systemic Treatment for Leishmania tropica Cutaneous Leishmaniasis
por: SOLOMON, Michal, et al.
Publicado: (2022)

Mutilating localized cutaneous leishmaniasis caused by Leishmania guyanensis()
por: Silva, Dina Fabrício da, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_csf60bcu69k0rdn899ama2tts8